real numbers, we do the math

Drug Dealing and Grand Theft – Now Legal

  • $62.7



    Drop in stock price

For the 7 months during 2016 that he was CEO of Valeant Pharmaceuticals, Joseph Papa was paid $62.7 million. Papa started in May of last year. During his tenure in 2016, Valeant's stock price fell 55%, the company lost $2.4 billion and revenue declined 7.4%.

— Source: